Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms

被引:48
作者
Castro, PD [1 ]
Liang, JC [1 ]
Nagarajan, L [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Div Pathol & Lab Med, Houston, TX 77030 USA
关键词
D O I
10.1182/blood.V95.6.2138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonrandom interstitial deletions and monosomy of chromosomes 5, 7, and 17 in refractory myelodysplasia (MDS) and acute myelogenous leukemia (AML) suggest a multistep pathway that culminates in aggressive clinical course. Because cytogenetic studies frequently identify chromosome 5 and 17 deletions within a single clone, we searched for allele loss for 5q loci and TP53 gene mutations in the same leukemic samples. Cosegregating deletions of chromosomes 5 and 17 were found to specifically include the 5q13,3 interval between the loci D5S672 and D5S620/D5S626, a locus hypothesized to harbor a tumor suppressor gene(1) and the TP53 gene on 17p. A rare patient with secondary refractory MDS and an unbalanced translocation [der(5;17)], which resulted in deletions of the 5q13,3-qter and 17p loci, provided clues on the sequence of genetic alterations. Serial molecular analysis of this patient revealed a dysplastic clone with der(5;17), which gave rise to a leukemic clone on acquiring an Inactivating mutation of TP53. Our findings are consistent with functional cooperation between a putative tumor suppressor gene at 5q13.3 that contributes toward the progression of early stages of MDS, and the TP53 gene when mutated, causes transformation to AML. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:2138 / 2143
页数:6
相关论文
共 31 条
[1]   Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer [J].
Achille, A ;
Baron, A ;
Zamboni, G ;
Di Pace, C ;
Orlandini, S ;
Scarpa, A .
BRITISH JOURNAL OF CANCER, 1998, 78 (12) :1653-1660
[2]   5Q DELETION - THE SOLE CHROMOSOME CHANGE IN A CARCINOMA OF THE BLADDER [J].
ATKIN, NB ;
FOX, MF .
CANCER GENETICS AND CYTOGENETICS, 1990, 46 (01) :129-131
[3]  
BIRCH JM, 1994, CANCER RES, V54, P1298
[4]  
Brothman AR, 1999, PROSTATE, V38, P303
[5]  
Cunningham JM, 1996, CANCER RES, V56, P4475
[6]  
ESTEY E H, 1987, Hematologic Pathology, V1, P203
[7]  
FAIRMAN J, 1994, PCR METH APPL, V4, P6
[8]   Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: Evidence for a novel critical locus [J].
Fairman, J ;
Wang, RY ;
Liang, H ;
Zhao, L ;
Saltman, D ;
Liang, JC ;
Nagarajan, L .
BLOOD, 1996, 88 (06) :2259-2266
[9]   Molecular biology of colorectal cancer [J].
Gryfe, R ;
Swallow, C ;
Bapat, B ;
Redston, M ;
Gallinger, S ;
Couture, J .
CURRENT PROBLEMS IN CANCER, 1997, 21 (05) :238-+
[10]   IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools [J].
Hainaut, P ;
Hernandez, T ;
Robinson, A ;
Rodriguez-Tome, P ;
Flores, T ;
Hollstein, M ;
Harris, CC ;
Montesano, R .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :205-213